Shah Gaurav
SEC CIK 1725922 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | CEO, Dir | 1.06M | $483.1K | $2.05M | 32 | 2022-02-07 | 2026-08-18 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 17:25 | 2026-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.38 | -2,293 | 1.06M | -0.2% | -$7,753 | |
| 2026-08-17 17:52 | 2026-08-13 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.38 | -2,837 | 1.06M | -0.3% | -$9,592 | |
| D | 2026-05-26 19:47 | 2026-05-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | M - OptEx | $1.69 | +76.5K | 1.12M | +7% | +$129.3K |
| D | 2026-05-26 19:47 | 2026-05-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale+OE | $3.09 | -55.7K | 1.06M | -5% | -$171.8K |
| 2026-05-21 16:06 | 2026-05-19 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.01 | -2,409 | 1.04M | -0.2% | -$7,261 | |
| 2026-05-14 16:19 | 2026-05-13 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.61 | -2,728 | 1.04M | -0.3% | -$9,837 | |
| 2026-02-20 | 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.34 | -5,990 | 1.05M | -0.6% | -$20.0K | |
| 2026-02-18 | 2026-02-13 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | S - Sale | $3.31 | -12.3K | 1.05M | -1% | -$40.6K | |
| D | 2026-02-13 | 2026-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO | A - Grant | $0.00 | +286.0K | 1.06M | +37% | $0 |
| 2025-11-20 | 2025-11-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $2.98 | -6,276 | 778.3K | -0.8% | -$18.7K | |
| 2025-08-20 | 2025-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | F - Tax | $3.05 | -2,234 | 784.6K | -0.3% | -$6,814 | |
| 2025-05-22 | 2025-05-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $6.45 | -2,253 | 786.8K | -0.3% | -$14.5K | |
| 2025-05-20 | 2025-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $6.53 | -3,621 | 789.1K | -0.5% | -$23.6K | |
| 2025-04-14 | 2025-04-10 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | P - Purchase | $5.08 | +20.0K | 792.7K | +3% | +$101.6K | |
| 2025-02-25 | 2025-02-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $10.58 | -16.3K | 772.7K | -2% | -$172.5K | |
| D | 2025-02-13 | 2025-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | A - Grant | $0.00 | +81.7K | 789.0K | +12% | $0 |
| 2024-11-25 | 2024-11-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $13.05 | -11.1K | 707.3K | -2% | -$144.7K | |
| 2024-08-20 | 2024-08-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $18.50 | -9,650 | 718.4K | -1% | -$178.5K | |
| DM | 2024-05-20 | 2024-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +17.7K | 636.5K | +3% | $0 |
| D | 2024-05-20 | 2024-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale+OE | $23.35 | -9,790 | 728.1K | -1% | -$228.6K |
| DM | 2024-05-20 | 2022-02-14+ | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | J - Other | $0.00 | +91.7K | 670.1K | +16% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $29.84 | -20.3K | 554.8K | -4% | -$604.9K |
| D | 2024-02-21 | 2024-02-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | A - Grant | $0.00 | +66.6K | 621.3K | +12% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | -46.8K | 575.0K | -8% | $0 |
| D | 2023-11-16 | 2023-11-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | -7,979 | 532.8K | -1% | $0 |
| 2023-08-21 | 2023-08-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $15.47 | -4,767 | 524.9K | -0.9% | -$73.7K | |
| D | 2023-08-15 | 2023-08-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +7,979 | 529.6K | +2% | $0 |
| 2023-05-19 | 2023-05-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $21.38 | -4,122 | 521.6K | -0.8% | -$88.1K | |
| D | 2023-05-16 | 2023-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +7,979 | 525.8K | +2% | $0 |
| DA | 2023-02-22 | 2023-02-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +31.4K | 549.1K | +6% | $0 |
| 2023-02-22 | 2023-02-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | S - Sale | $19.06 | -12.2K | 536.9K | -2% | -$232.4K | |
| 2022-02-08 | 2022-02-07 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | CEO, Dir | P - Purchase | $17.34 | +22.0K | 517.6K | +4% | +$381.5K |
Purchase Sale Sale after option exercise All abbreviations